Using current estimates of US long-COVID burden (assuming the probability of long COVID is 6% and symptoms last 1 year), cases cost an average of $2.01 billion annually. The economic burden of long COVID already surpasses that of carpal tunnel, Lyme disease, and psoriasis, the authors said, and is likely to continue to grow.